POSID 1 vial 5ML (Etoposide 100mg)

• Small cell lung carcinoma
  
  
• Ovarian carcinoma
  
  
• Hodgkin's and non-Hodgkin's lymphomas
  
  
• Acute leukemia
  
  
• Germ cell tumours
  
  
• Other responsive malignancies

Administered by intravenous infusion in a clinical setting. Dosage is calculated based on body surface area, patient condition, and chemotherapy protocol. Often used in multi-drug regimens under strict medical supervision.

Contraindications:

• Hypersensitivity to Etoposide
  
  
• Severe bone marrow suppression
  
  
• Significant hepatic or renal impairment
  
  
• Active infections
  
  
• Pregnancy and breastfeeding
  
  

Side effects:

• Myelosuppression (leukopenia, thrombocytopenia)
  
  
• Nausea, vomiting
  
  
• Hair loss
  
  
• Elevated liver enzymes
  
  
• Hypersensitivity reactions
  
  
• Hypotension
  
  
• Rare: anaphylactoid reactions